跳至主要内容
临床试验/EUCTR2019-004178-24-NL
EUCTR2019-004178-24-NL进行中(未招募)1 期

Defining long-term macrolide maintenance therapy in COPD: a single center randomized controlled trial: - Vasco da Gama

Amphia0 个研究点目标入组 64 人开始时间: 2020年6月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • COPP patients with azithromycin maintenance therapy for at least 12 montsh and who have a stable exacerbation rate (2 or less exacerbations a year).
  • The initial indication for azithromycin maintenance therapy should be frequent exacerbations (>3 exacerbations a year)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 24
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • Bronchiectasis
  • Antibiotics and prednisolon treatment because of an exacerbation in the last month
  • prednisolone maintenance more than 5mg a day

研究者

发起方
Amphia

相似试验